- Home
- TIL vs FORA Comparison
TIL vs FORA Comparison
Compare TIL & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- FORA
- Stock Information
- Founded
- TIL 2018
- FORA 2014
- Country
- TIL United States
- FORA United States
- Employees
- TIL N/A
- FORA 37
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- TIL Health Care
- FORA Technology
- Exchange
- TIL Nasdaq
- FORA Nasdaq
- Market Cap
- TIL 177.1M
- FORA 69.4M
- IPO Year
- TIL 2021
- FORA N/A
- Fundamental
- Price
- TIL $21.55
- FORA $2.27
- Analyst Decision
- TIL Buy
- FORA Strong Buy
- Analyst Count
- TIL 6
- FORA 1
- Target Price
- TIL $120.50
- FORA $5.00
- AVG Volume (30 Days)
- TIL 145.1K
- FORA 75.0K
- Earning Date
- TIL 11-12-2025
- FORA 11-12-2025
- Dividend Yield
- TIL N/A
- FORA N/A
- EPS Growth
- TIL N/A
- FORA N/A
- EPS
- TIL N/A
- FORA N/A
- Revenue
- TIL N/A
- FORA $25,031,040.00
- Revenue This Year
- TIL N/A
- FORA $47.82
- Revenue Next Year
- TIL N/A
- FORA $10.11
- P/E Ratio
- TIL N/A
- FORA N/A
- Revenue Growth
- TIL N/A
- FORA 18.59
- 52 Week Low
- TIL $10.80
- FORA $1.64
- 52 Week High
- TIL $73.69
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- TIL 38.52
- FORA 60.82
- Support Level
- TIL $22.67
- FORA $2.20
- Resistance Level
- TIL $25.89
- FORA $2.39
- Average True Range (ATR)
- TIL 2.61
- FORA 0.13
- MACD
- TIL -0.62
- FORA 0.02
- Stochastic Oscillator
- TIL 10.46
- FORA 76.47
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.